Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / AUPH - Aurinia Should Be A Long-Term Winner With Lupkynis Now On The Market

AUPH - Aurinia Should Be A Long-Term Winner With Lupkynis Now On The Market

Aurinia Pharmaceuticals Inc
  • Aurinia saw its first product, Lupkynis, approved and launched in January, and analysts widely expect it to be a blockbuster.
  • Despite completely removing regulatory risk from the picture, shares are essentially unmoved since before approval.
  • With a market cap just under $2 billion, Aurinia presents a low downside/high upside potential opportunity for patient investors.

For further details see:

Aurinia Should Be A Long-Term Winner With Lupkynis Now On The Market
Stock Information
Company Name: Aurinia Pharmaceuticals Inc
Stock Symbol: AUPH
Market: NASDAQ
Website: auriniapharma.com
Menu
AUPH AUPH Quote AUPH Short AUPH News AUPH Articles AUPH Message Board
Get AUPH Alerts

News, Short Squeeze, Breakout and More Instantly...